Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ASCAPE

Financiado

Artificial intelligence Supporting CAncer Patients across Europe

The latest cancer statistics highlight encouraging advances in decreasing cancer-related mortality. However, given that one in two people will be diagnosed with cancer in their lifetime, and due to the growing and ageing populatio... ver más

30/06/2023

UBITECH DESIGN PLA...

5M€

Presupuesto del proyecto: 5M€

Líder del proyecto

GIOUMPITEK MELETI SCHEDIASMOS YLOPOIISI KAI P... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 18 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-06-30

SC1-DTH-01-2019: Big data and Artificial Intelligenc...

I+D

Cerrada hace 5 años

0% 100% 100%

18 Participantes

UBITECH DESIGN PLANNING IMPL...

637.25K€ | Lider

HAZERA ESPAÑA 90

SPHYNX TECHNOLOGY SOLUTIONS...

481.25K€ | Participante

CARE ACROSS LTD

408.13K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PRE2018-084836 DEEPEMR: EXTRACCION DE INFORMACION CLINICA USANDO DEEP LEARN... 93K€ Cerrado

CLARIFY Cancer Long Survivors Artificial Intelligence Follow Up 5M€ Cerrado

BETTER Better rEal-world healTh-daTa distributEd analytics Research... 10M€ Cerrado

TED2021-132025B-C41 COORDINACION Y FEDERACION DE DATOS PARA UN ANALITICA DISTRIB... 524K€ Cerrado

TIN2017-87548-C2-1-R DEEPEMR: EXTRACCION DE INFORMACION CLINICA USANDO DEEP LEARN... 117K€ Cerrado

PID2020-116898RB-I00 INTELIGENCIA ARTIFICIAL PARA PROCESAMIENTO DE LENGUAJE NATUR... 110K€ Cerrado

Duración del proyecto: 43 meses Fecha Inicio: 2019-11-06
Fecha Fin: 2023-06-30

Líder del proyecto

GIOUMPITEK MELETI SCHEDIASMOS YLOPOIISI KAI P... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 5M€

Descripción del proyecto The latest cancer statistics highlight encouraging advances in decreasing cancer-related mortality. However, given that one in two people will be diagnosed with cancer in their lifetime, and due to the growing and ageing population, the absolute number of people living with cancer is set to keep increasing substantially in the near future. The main objective of ASCAPE is to take advantage of the recent ICT advances in Big Data, Artificial Intelligence and Machine Learning to support cancer patients’ quality of life and health status. To achieve its objective, ASCAPE will create an open AI infrastructure that will enable health stakeholders (hospitals, research institutions, companies, etc.) to deploy and execute its AI algorithms locally on their private data. Any new knowledge produced by this process will be sent back to the open AI infrastructure. This way the knowledge will be shared among everyone while the medical data will still remain private. The services to be designed, piloted and deployed inside this project will include intelligent interventions for physiological and psychological support, improved patient and family counselling and guidance, early diagnosis and forecasts of ill-health, identification of disease trajectories and relapse, improved health literacy etc. ASCAPE will focus the training of the AI in two types of cancer, breast and prostate. This way, it will achieve sufficient coverage across genders as well as age groups, hence facilitating its ongoing improvements and applicability towards any type of cancer in the future. The ASCAPE project will be developed in 36 months by a competitive consortium of 15 partners from 7 countries, which corresponds to a well-balanced structure, involving big companies, SMEs, research centres and universities. Despite the great diversity of entities within the proposal, ASCAPE partners bring state-of-the-art complementary skills ensuring the ability of the consortium to develop the proposed solutions.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores